Decitabine
FDA Approved: * July 11, 2013Pharm Company: * DR REDDYS LABS LTD
Category: Cancer
Decitabine, sold under the brand name Dacogen, acts as a nucleic acid synthesis inhibitor.[1] It is a medication for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).[2] Chemically, it is a cytidine analog. Contents 1 Medical uses 2 Pharmacology 3 Research 3.1 Atherosclerosis 4 References 5 Further reading 6 External links Medical uses Decitabine is used... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Decitabine 50 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0143-9385
Labeler:
Hikma Pharmaceuticals USA Inc.
Decitabine 50 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0781-3139
Labeler:
Sandoz Inc
Decitabine 50 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0781-3296
Labeler:
Sandoz Inc
Decitabine 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16714-749
Labeler:
Northstar Rxllc
Decitabine 50 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16714-928
Labeler:
Northstar Rx LLC
Decitabine 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16729-224
Labeler:
Accord Healthcare Inc.
Decitabine 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 25021-219
Labeler:
Sagent Pharmaceuticals
Decitabine 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 25021-231
Labeler:
Sagent Pharmaceuticals
Decitabine 50 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 42737-110
Labeler:
Chemi Pharma LLC
Decitabine 50 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 43598-348
Labeler:
Dr.reddy's Laboratories Inc
Related Brands
Drugs with the same active ingredients